Contrasting Nanovibronix (NASDAQ:FEED) and Green Thumb Industries (OTCMKTS:GTBIF)

Green Thumb Industries (OTCMKTS:GTBIF – Get Free Report) and Nanovibronix (NASDAQ:FEED – Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, institutional ownership, valuation and dividends.

Insider & Institutional Ownership

0.1% of Green Thumb Industries shares are held by institutional investors. Comparatively, 16.4% of Nanovibronix shares are held by institutional investors. 9.4% of Green Thumb Industries shares are held by company insiders. Comparatively, 12.2% of Nanovibronix shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Risk and Volatility

Green Thumb Industries has a beta of 1.28, meaning that its stock price is 28% more volatile than the S&P 500. Comparatively, Nanovibronix has a beta of 1.46, meaning that its stock price is 46% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent ratings for Green Thumb Industries and Nanovibronix, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Green Thumb Industries 0 1 1 1 3.00
Nanovibronix 1 0 0 0 1.00

Green Thumb Industries presently has a consensus price target of $18.00, suggesting a potential upside of 174.39%. Given Green Thumb Industries’ stronger consensus rating and higher possible upside, research analysts clearly believe Green Thumb Industries is more favorable than Nanovibronix.

Profitability

This table compares Green Thumb Industries and Nanovibronix’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Green Thumb Industries 10.48% 6.03% 4.09%
Nanovibronix -1,093.61% -60.73% -48.48%

Earnings and Valuation

This table compares Green Thumb Industries and Nanovibronix”s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Green Thumb Industries $1.18 billion 1.09 $114.15 million $0.54 12.15
Nanovibronix $1.93 million 0.12 -$18.18 million ($117.28) -0.00

Green Thumb Industries has higher revenue and earnings than Nanovibronix. Nanovibronix is trading at a lower price-to-earnings ratio than Green Thumb Industries, indicating that it is currently the more affordable of the two stocks.

Summary

Green Thumb Industries beats Nanovibronix on 12 of the 15 factors compared between the two stocks.

About Green Thumb Industries

(Get Free Report)

Green Thumb Industries Inc. manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands. It distributes its products primarily to third-party retail customers and sells finished products directly to consumers in its own retail stores, as well as direct-to consumer delivery channel. Green Thumb Industries Inc. was founded in 2014 and is headquartered in Chicago, Illinois.

About Nanovibronix

(Get Free Report)

NanoVibronix Inc. is a medical device company that is focused on creating medical products utilizing its proprietary low-intensity, surface acoustic wave technology. … NanoVibronix’ catheter-based products include the UroShield™ and NG-Shield™ devices that are both CE mark certified.

Receive News & Ratings for Green Thumb Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Green Thumb Industries and related companies with MarketBeat.com's FREE daily email newsletter.